4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-17-000056
CIK 0000899866operating
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 7:45 PM ET
Size
10.4 KB
Accession
0000899866-17-000056
Insider Transaction Report
Form 4
Thiel Carsten
SVP, EMEA & Asia Pacific
Transactions
- Award
Option to Purchase Common Stock
2017-02-28+14,800→ 29,600 totalExercise: $131.25From: 2018-02-28Exp: 2027-02-28→ Common Stock, par value $.0001 per share (14,800 underlying) - Sale
Common Stock, par value $.0001 per share
2017-02-28−54→ 30,143 total - Sale
Common Stock, par value $.0001 per share
2017-02-27$131.20/sh−71$9,315→ 30,197 total - Award
Common Stock, par value $.0001 per share
2017-02-28+7,500→ 37,643 total
Footnotes (4)
- [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]Award of Restricted Stock Units under the 2004 Incentive Plan. 25% vests on each anniversary of the grant date.
- [F4]Stock option award under 2004 Incentive Plan. 25% vest on the first anniversary of the grant date, 1/16 every three months thereafter until fully vested over 4 years.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 7:45 PM ET
- Size
- 10.4 KB